PARD (PARD) Stock Price & Analysis
PARD (PARD) rose 0.00% to USD 0 as of June 10, 2026 at 04:03 UTC, according to Nexqual real-time market data.
PARD last closed at USD 0; the session ranged USD 0–0 on volume of 7 shares. Market capitalization is $149, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 04:03 UTC.
Key Statistics (as of June 10, 2026 at 04:03 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 7 shares |
| Market Cap | $149 |
| Exchange | PNK |
Technical Analysis (PARD)
Nexqual's technical model rates PARD "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 04:03 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (PARD)
Wall Street analysts rate PARD "None", per Nexqual as of June 10, 2026 at 04:03 UTC.
| Consensus Rating | None |
|---|
Earnings (PARD)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2011-09-30 | USD -2.4 vs est -4.56 ▲ beat |
| 2011-06-30 | USD -2.8 vs est -4.52 ▲ beat |
| 2011-03-31 | USD -2.4 vs est -4.52 ▲ beat |
| 2010-12-31 | USD -3.36 vs est -7.49 ▲ beat |
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Financials & Fundamentals (PARD)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -210.37% |
| Debt / Equity | 52.62 |
| Current Ratio | 0.76 |
| Total Cash | $1.98M |
| Total Debt | $1.64M |
| Free Cash Flow | $-4.53M |
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Financial Health Score (PARD)
Nexqual rates PARD's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 04:03 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $2M cash vs $2M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$10M |
| Efficiency | Critical — ROE -210%, ROA -46.0% |
Ownership (PARD)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 1.50M |
| Short % of Float | +4.11% |
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARYX | ARYX THERAPEUTICS INC | USD 0 | ▲ 0% |
| MITI | MITESCO, INC. | USD 0.08 | ▼ 6.25% |
| PANC | PANACOS PHARMACEUTICALS INC | USD 0 | ▲ 0% |
| AFFY | AFFYMAX INC | USD 0 | ▲ 0% |
| NTII | NEUROBIOLOGICAL TECHNOLOGIES IN | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:03 UTC. This page is informational and not investment advice.